Introduction
============

In recent years, stroke seems to have become a less severe disease.[@b1] Several authors have studied prognostic factors for mortality and dependency after stroke in attempts to identify and intervene with risk factors determining the stroke outcome. Well-defined prediction models of outcome could also have important implications in clinical practice in guiding the management and improving information to patients and relatives. It is well established that high age and severe impairment predict a poor outcome after a stroke. Other known prognostic factors for 30-day survival include cardiac failure, level of consciousness and grade of impairment.[@b2] Appelros *et al* performed one of the few population-based studies on this matter, and their study also took into account pre-stroke conditions. In their cohort in Örebro, Sweden (n=377) followed up for 1 year post-stroke, heart disease and dementia were found to have predictive power for mortality and morbidity.[@b3] [@b4] Pre-stroke risk factors for stroke severity need to be studied in greater detail and with longer follow-up.

In earlier studies of the cohort participating in the Uppsala Longitudinal Study of Adult Men (ULSAM), we observed that besides traditional stroke risk factors, performance in the cognitive test Trail Making Test (TMT)-B at age 70 carried important information as a predictor of later incidence of stroke, especially brain infarction (BI).[@b5] A poor result in the latter test is believed to represent subclinical cognitive deficits due to silent cerebrovascular disease.[@b6] In the present study, we addressed the question whether cognitive function measured with TMT-A and -B and the Mini-Mental State Examination (MMSE) in the pre-stroke setting were associated with risk of mortality after first-ever stroke. These questions were investigated in an extensively characterised community-based sample of 70-year-old men followed for up to 14 years through registry data from the Swedish National Board of Health and Welfare and discharge records.

Methods
=======

Study sample
------------

The study was based on the ULSAM cohort (<http://www.pubcare.uu.se/ULSAM>) participating in a health investigation focusing on identification of metabolic risk factors for cardiovascular disease, to which all 50-year-old men living in Uppsala, Sweden, in 1970--1974 were invited. The ULSAM originally comprised 2322 participants (82% of the invited). A re-investigation was performed around 20 years later between 1991 and 1995. Of the 1681 participants available who were invited to that investigation, 1221 (73%) attended. Seventy-eight participants were excluded because of a history of stroke/transient ischaemic attack (TIA) before the investigation and eight because of misdiagnosis in the registry, rendering 1135 men eligible. In subsequent tests of cognitive function performed in 1993--1996, 930 of the eligible participants took part. After additional exclusion of 11 participants who had had a stroke/TIA between the baseline examination and the cognitive testing, 919 were available for the present study. All medical records from the hospitalisation of those suffering a first-ever stroke/TIA were reviewed by one physician (BW).

In the whole ULSAM cohort based on the investigation at age 50 (n=2322), 232 men had experienced a first stroke and 586 had died, before the planned date of cognitive function tests.

Clinical examinations
---------------------

The ULSAM examinations have previously been described in detail.[@b7] [@b8] The baseline investigation for the present study was performed when the participants were 69--75 years old and included a medical questionnaire concerning previous diseases, alcohol habits and medical treatment. The participants were physically examined, including anthropometric measurements. Supine blood pressure was measured under standardised conditions. Hypertension was defined as a supine blood pressure of 140/90 mm Hg or higher and/or treatment with antihypertensive drugs. Blood samples were drawn in the morning after an overnight fast. Cholesterol concentrations were measured in serum by enzymatic techniques using IL test cholesterol Trinder\'s Method for use in a Monarch apparatus (Instrumentation Laboratories, Lexington, KT, USA). High-density lipoprotein particles were separated by precipitation with magnesium chloride/phosphotungstate. Diabetes was defined according to the 1997 criteria of American Diabetes Association.[@b9] A standard 12-lead ECG was recorded. The revised Minnesota code was used for classification,[@b10] [@b11] and left ventricular hypertrophy (LVH) was defined as high-amplitude R-waves together with a left ventricular strain pattern. The coding of education was as follows: (1) elementary school only (6--8 years), (2) secondary school (12 years) and (3) 3 or more years of college or graduate examination. The coding of smoking and social group classification was based on interview reports. The three conventional social classes were used and classified in accordance with the Central Bureau of Statistics.[@b12]

Cognitive function tests
------------------------

In TMT-A, the participant is asked to draw lines with a pencil between numbers in ascending order, as fast as possible.[@b13] In TMT-B, letters are also added, and the task is to alternate between letters and numbers in ascending order. The score is equal to the time taken to complete the test, in seconds. The standard TMT-A consists of digits 1--25 and TMT-B consists of digits and letters (1-A-2-B- ... -K-12-L-13). The maximum time set for TMT-B was 240 s, and 41 participants reached that level. A long completion time reflects impaired psychomotor speed.

The MMSE[@b14] is a screening test for dementia and cognitive decline and is widely used both in clinical practice and in research. It has the advantage of being easy to administer and has a high replicability, but from clinical practice, it is known to only give a limited information of cognitive performance in the patients with stroke. The scores range from 0 (worst) to 30 (best). MMSE was added to the test battery after the start, and thus, the number of participants is slightly smaller than in the other cognitive tests. The cognitive examinations have been described earlier in detail.[@b5]

Follow-up
---------

The sample was followed up from the first investigation at age 70, that is, from August 1991--May 1995 to 31 December 2006. None of the subjects was lost to follow-up.

End point
---------

Stroke/TIA and survival were recorded on the bases of the Swedish Hospital Discharge Record and Cause of Death Registries and validated by examination of all the medical records by one physician (BW). The stroke cases investigated in the present study were as follows:

1.  Fatal or non-fatal stroke or TIA (ICD-9 codes 430--31 and 434--436, ICD-10 codes I60--61, I63.0--I63.5, I63.8--9, I64 and G45).

2.  Fatal or non-fatal BI (ICD-9 code 434; ICD-10 codes I63.0--I63.5 and I63.8--9). The end points were mortality after a first-ever stroke/TIA-event.

Statistical methods
-------------------

Distributions were tested for normality by the Shapiro--Wilk W test, and logarithmic transformation was performed when necessary to obtain normality (TMT-A and -B). The prognostic value of a 1SD increase in the continuous variables or transfer from one level to another of the dichotomous variables was investigated with Cox proportional HRs. Four MMSE groups as equal in size as possible were considered (≤27, 28, 29 and 30 points). Interaction terms between all baseline covariates were examined, and no evidence of effect modification was found. We examined three sets of models in a hierarchical fashion:Models A adjusting for age at baseline.Models B adjusting for age, education and social group at baseline.Models C adjusting for the following baseline covariates: age, education, social group, systolic blood pressure, hypertension treatment, serum cholesterol, diabetes mellitus, atrial fibrillation, ECG-LVH and current smoking.

Proportional hazards assumptions were confirmed graphically and by Schoenfeld\'s test. Two-tailed 95% CIs and p values were given, with p\<0.05 regarded as significant.

Kaplan--Meier curves for TMT-A and -B in tertiles were used for survival estimates. Authors BW and LB performed all statistical analyses, using Stata V.10.1 (Stata Corporation).

Results
=======

Characteristics from the examination at age 70 years are presented in [table 1](#tbl1){ref-type="table"}. The mortality incidence rate among the 155 subjects with stroke/TIA was 148/1000 person-years at risk (PYAR) (84 deaths during 566 PYAR). The median follow-up to the first stroke/TIA event was 11.2 years (maximum 13.6 years), and the median follow-up after first-ever stroke/TIA was 2.5 years (maximum 12.2 years), contributing to 566 PYAR. A total of 84 men died during the time of follow-up (54%), of which 22 died within 1 month (14%) and 42 within 1 year (27%). The diagnoses were BI in 97 cases, intracerebral haemorrhage in 24 cases and the rest being TIA, unspecified stroke or subarachnoid haemorrhage. Of those suffering a BI, 53 died during follow-up.

###### 

Baseline characteristics at age 70

                                                            All participants (n=919)   Participants with stroke/TIA (n=155)
  --------------------------------------------------------- -------------------------- --------------------------------------
  Systolic blood pressure (mm Hg)                           146 (18)                   151 (19)
  S-total cholesterol (mmol/l)                              5.8 (1.0)                  5.9 (1.1)
  Atrial fibrillation                                       36 (4%)                    9 (10%)
  ECG-LVH                                                   65 (7%)                    14 (16%)
  Hypertension prevalence                                   676 (74%)                  82 (84%)
  Diabetes prevalence                                       159 (17%)                  21 (22%)
  Treatment with hypertension medicine                      306 (33%)                  44 (45%)
  Treatment with diabetes medicine                          48 (5%)                    7 (7%)
  Treatment with lipid-lowering medicine                    80 (9%)                    14 (16%)
  Current cigarette smoking                                 174 (19%)                  23 (24%)
  Education                                                                            
   Elementary school only (7 or 8 years)                    571 (81%)                  53 (74%)
   Secondary school (12 years)                              51 (7%)                    8 (11%)
   Three or more years of college or graduate examination   107 (15%)                  11 (15%)
  Social group                                                                         
   Low                                                      388 (42%)                  39 (40%)
   Middle                                                   361 (39%)                  36 (37%)
   High                                                     169 (18%)                  22 (23%)
  Mini-Mental State Examination                                                        
   Group ≤27 points                                         182 (22%)                  21 (24%)
   Group 28 points                                          181 (22%)                  20 (23%)
   Group 29 points                                          264 (32%)                  27 (31%)
   Group 30 points                                          192 (23%)                  18 (21%)
  Trail Making Test-A (seconds)                             47 (20)                    48 (20)
  Trail Making Test-B (seconds)                             119 (48)                   127 (46)

Data are presented as means (SDs) or numbers of individuals (%).

Diabetes is defined according to the 1997 American Diabetes Association criteria.

LVH, left ventricular hypertrophy; S, serum; TIA, transient ischaemic attack.

Relations of baseline variables at age 70 to the first-ever stroke mortality up to the end of follow-up are presented in [table 2](#tbl2){ref-type="table"}. In Cox proportional hazard models adjusting for age at baseline, the prevalence of ECG-LVH, diabetes and treatment with antihypertensives at baseline were strongly related to death after first-ever stroke. This was also true when the subgroup of BIs was analysed in all models (eg, HR 2.40, 95% CI 1.24 to 4.66 for ECG-LVH prevalence and HR 2.01, 95% CI 1.06 to 3.80 for diabetes prevalence in models C). No other investigated variable showed any significant relation to mortality in the total stroke sample or in the subgroup of BIs in these analyses except for treatment with lipid lowering in the subgroup of BIs.

###### 

Relations of baseline clinical variables to mortality after first-ever stroke

                                           All stroke/TIA (n=155), 84 died during follow-up   Brain infarction (n=97), 53 died during follow-up
  ---------------------------------------- -------------------------------------------------- ---------------------------------------------------
  Systolic blood pressure (mm Hg)          1.00 (0.99 to 1.02)                                1.00 (0.98 to 1.01)
  p=0.418                                  p=0.730                                            
  S-total cholesterol (mmol/l)             0.85 (0.69 to 1.04)                                0.88 (0.66 to 1.17)
  p=0.122                                  p=0.384                                            
  Atrial fibrillation                      1.14 (0.56 to 2.29)                                0.54 (0.20 to 1.43)
  p=0.722                                  p=0.216                                            
  ECG-LVH                                  1.88 (1.04 to 3.39)                                2.54 (1.25 to 5.15)
  p=0.035                                  p=0.010                                            
  Hypertension prevalence                  1.19 (0.64 to 2.20)                                1.66 (0.74 to 3.71)
  p=0.576                                  p=0.217                                            
  Diabetes prevalence                      1.67 (1.04 to 2.69)                                1.85 (1.00 to 3.41)
  p=0.035                                  p=0.050                                            
  Treatment with antihypertensives         1.56 (1.02 to 2.40)                                2.60 (1.50 to 4.50)
  p=0.042                                  p=0.001                                            
  Treatment with antidiabetics             1.28 (0.71 to 2.39)                                1.48 (0.58 to 3.77)
  p=0.514                                  p=0.410                                            
  Treatment with lipid-lowering medicine   1.53 (0.83 to 2.84)                                2.17 (1.01 to 4.65)
  p=0.173                                  p=0.046                                            
  Current cigarette smoking                0.97 (0.56 to 1.69)                                1.05 (0.54 to 2.04)
  p=0.921                                  p=0.885                                            

Data are presented as Cox proportional HRs (95% CI) for a 1SD increase in the continuous variables or transfer from one level to another of the dichotomous variables.

LVH, left ventricular hypertrophy; S, serum; TIA, transient ischaemic attack.

Both TMT-A and -B strongly predicted survival in Cox proportional hazard analyses, but no significant relation between MMSE scores and future mortality was seen ([table 3](#tbl3){ref-type="table"}).

###### 

Relations of baseline cognitive function variables to mortality after first-ever stroke/TIA

                            All stroke/TIA (n=155), 84 died during follow-up   Brain infarction (n=97), 53 died during follow-up                                                                      
  ------------------------- -------------------------------------------------- --------------------------------------------------- ---------------------- --------------------- --------------------- ---------------------
  Trail Making Test-A                                                                                                                                                                                 
   As continuous variable   1.45 (1.15 to 1.82)                                1.67 (1.24 to 2.23)                                 1.88 (1.31 to 2.71)    1.27 (0.92 to 1.76)   1.47 (0.96 to 2.25)   1.45 (0.97 to 2.17)
  p=0.002                   p=0.001                                            p=0.001                                             p=0.137                p=0.075               p=0.068               
   Tertile 1                1                                                  1                                                   1                      1                     1                     1
   Tertile 2                1.47 (0.84 to 2.56)                                1.54 (0.73 to 3.27)                                 2.09 (0.85 to 5.11)    1.54 (0.76 to 3.09)   1.41 (0.51 to 3.86)   1.91 (0.82 to 4.47)
  p=0.173                   p=0.258                                            p=0.107                                             p=0.226                p=0.505               p=0.133               
   Tertile 3                1.84 (1.07 to 3.17)                                2.26 (1.13 to 4.53)                                 2.90 (1.24 to 6.77)    1.33 (0.65 to 2.73)   1.43 (0.54 to 3.75)   1.59 (0.64 to 3.92)
  p=0.027                   p=0.021                                            p=0.014                                             p=0.442                p=0.468               p=0.315               
  Trail Making Test-B                                                                                                                                                                                 
   As continuous variable   1.20 (0.96 to 1.51)                                1.79 (1.21 to 2.66)                                 2.01 (1.28 to 3.15)    1.00 (0.74 to 1.35)   1.63 (0.90 to 2.95)   1.15 (0.77 to 1.72)
  p=0.115                   p=0.004                                            p=0.002                                             p=0.985                p=0.108               p=0.488               
   Tertile 1                1                                                  1                                                   1                      1                     1                     1
   Tertile 2                1.55 (0.86 to 2.81)                                1.57 (0.70 to 3.53)                                 2.11 (0.82 to 5.46)    0.83 (0.39 to 1.76)   0.72 (0.21 to 2.43)   0.74 (0.30 to 1.85)
  p=0.149                   p=0.275                                            p=0.124                                             p=0.632                p=0.597               p=0.521               
   Tertile 3                1.63 (0.91 to 2.92)                                3.07 (1.22 to 7.73)                                 3.53 (1.21 to 10.34)   0.96 (0.47 to 1.96)   1.53 (0.42 to 5.49)   1.40 (0.58 to 3.35)
  p=0.103                   p=0.017                                            p=0.021                                             p=0.915                p=0.516               p=0.452               
  MMSE                                                                                                                                                                                                
   Group 30 points          1                                                  1                                                   1                      1                     1                     1
   Group ≤27 points         1.22 (0.63 to 2.34)                                1.35 (0.55 to 3.31)                                 0.81 (0.23 to 2.86)    0.52 (0.22 to 1.22)   0.71 (0.21 to 2.39)   0.54 (0.17 to 1.71)
  p=0.558                   p=0.518                                            p=0.746                                             p=0.132                p=0.584               p=0.293               
   Group 28 points          1.56 (0.80 to 3.04)                                1.92 (0.84 to 4.43)                                 1.80 (0.65 to 4.97)    1.17 (0.51 to 2.67)   2.08 (0.67 to 6.45)   1.09 (0.36 to 3.32)
  p=0.197                   p=0.123                                            p=0.259                                             p=0.715                p=0.205               p=0.874               
   Group 29 points          1.03 (0.55 to 1.91)                                1.35 (0.61 to 2.98)                                 1.27 (0.53 to 3.04)    0.63 (0.26 to 1.49)   0.85 (0.24 to 2.94)   0.42 (0.14 to 1.26)
  p=0.928                   p=0.456                                            p=0.596                                             p=0.294                p=0.795               p=0.122               

Data are presented as Cox proportional HRs (95% CIs) for a 1SD increase in the continuous variables or transfer from one level to another of the dichotomous variables.

MMSE 30 points and TMT-A and -B tertile 1 were used as references.

MMSE, Mini-Mental State Examination; TIA, transient ischaemic attack.

Kaplan--Meier survival estimates for TMT-A by tertiles are displayed in [figure 1](#fig1){ref-type="fig"} and for TMT-B by tertiles in [figure 2](#fig2){ref-type="fig"}. The survival decreased gradually with higher tertiles.

![Kaplan--Meier survival estimates for Trail Making Test A in tertiles.](bmjopen-2011-000458fig1){#fig1}

![Kaplan--Meier survival estimates for Trail Making Test B in tertiles.](bmjopen-2011-000458fig2){#fig2}

Incidence rates were similar in stratified analyses by tertiles of the independent variables, suggesting no major deviation from linearity (data not shown).

Discussion
==========

In this community-based sample of elderly men, free from stroke/TIA at baseline, pre-stroke executive function, as measured by TMT-A and -B, predicted survival independent of education, social group and traditional stroke risk factors, as described in previous studies,[@b15; @b16; @b17; @b18] whereas MMSE had no predictive power in this respect. Failure in our study to detect association to MMSE could be explained by a good general cognitive performance. As no one in the sample had a MMSE score \<21 points and the median score was 29 points, our sample represents a non-demented population.

In a systematic review article validating prognostic models by Counsell *et al*, cardiac failure, level of consciousness and grade of impairment were the predictors of survival after 30 days in patients with stroke. Pre-stroke overt dementia has previously been observed to be a predictor for initial stroke severity and 28-day and 1-year case death.[@b3] [@b4] [@b19] Patients with small-vessel disease have an augmented risk of death after a stroke event.[@b20]As poor performance in TMT-A and -B in a non-demented population may be interpreted as impaired subcortical function, our findings regarding survival point in the same direction. The present study is unique in its kind since the cognitive function evaluation was performed up to 12 years before the stroke event.

Executive dysfunction in an elderly population may be a manifestation of clinically unrealised cerebrovascular disease[@b21] and seems to be an objective in small vessel disease.[@b22] Lines of research suggest associations between vascular risk factors, such as age, hypertension, smoking and glucometabolic disturbances,[@b23; @b24; @b25; @b26] and brain atrophy, white matter abnormalities and silent cerebral infarctions.[@b6] [@b27; @b28; @b29] These vascular risk factors could be the cause of brain lesions, not yet recognised clinically, and earlier studies have shown associations between cerebrovascular risk factor burden and a broad range of cognitive abilities.[@b30] [@b31] Ischaemic small vessel disease is recently underlined as a potentially severe condition prodrome of subcortical vascular dementia.[@b20]

Biological ageing of the brain is partly attributable to ageing of the cerebrovascular circulation and effects of these vascular changes on the brain.[@b32] [@b33]Mid-life stroke risk factors have been related to late-life cognitive impairment. The importance of managing stroke risk factors is further reinforced by the inverse association between global atrophy measured with MRI and results from cognitive testing.[@b31]

Earlier cross-sectional studies on the ULSAM cohort have also demonstrated that high 24-h BP, non-dipping, insulin resistance and diabetes were all related to low cognitive function.[@b33] Our own earlier studies on this cohort indicated that the risk of BI was increased in men with poor TMT-B test results.[@b5]

Remarkable in this study, as the risk of stroke/TIA related to TMT-A and -B scores increase when adjusting for education and social factors (models B) and further in the multivariable-adjusted model (models C), is that the risk related to the tests seem to exist separately, beside the track of traditional stroke risk factors.

Our study has strengths. It is based on a large community-based sample, and it has a long follow-up with a large number of persons with incident stroke, non-existent loss to follow-up and extensive information on traditional risk factors, reducing the risk of confounding. All stroke and TIA cases have been examined in detail through medical records. The sample is also representative of the general population in Sweden regarding stroke incidence, according to data published by the Swedish National Board of Health and Welfare (<http://www.sos.se/sosmeny.htm>). The accuracy of the Swedish Hospital Discharge Record and the Cause of Death Registries has been shown to be high regarding stroke diagnosis.[@b34] Limitations include an unknown generalisability to women and to other age and ethnic groups, as only men of similar age and ethnic background were examined. The present cohort has been re-examined a few times since baseline and risk factors have been treated and the men of the cohort may therefore have been healthier during follow-up than the average man of the same age. It is unlikely, however, that this would have influenced the associations we have demonstrated in our study.

Regarding TMT-A and -B, it has been suggested that the difference between the two tests might be a more pure measure of executive function independent from individual differences in psychomotor speed.[@b35] However, creating a difference or a ratio may also introduce bias in the estimate and increases the measurement error why we chose not to.

Pre-stroke cognitive performance measured with TMT-A and -B in a population-based study strongly predicted post-stroke mortality independent of education, socioeconomic status or traditional risk factors. Thus, TMT-A and -B, easily accessible cognitive tests for clinical use, may not only be used as tools for identifying risk of stroke but may also be considered important predictors of post-stroke mortality.
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